A research paper, entitled “Multi-omics and clustering analyses reveal the mechanisms underlying unmet needs for patients with lung adenocarcinoma and identify potential therapeutic targets” was published in the Molecular Cancer on Sep.2, 2024.
The research team includes Ken Asada (Senior Research Scientist) and Ryuji Hamamoto (Team Leader) of the Cancer Translational Research Team at RIKEN AIP as corresponding authors.
Authours:
Ken Asada (* Corresponding Author), Syuzo Kaneko, Ken Takasawa, Kouya Shiraishi, Norio Shinkai, Yoko Shimada, Satoshi Takahashi, Hidenori Machino, Kazuma Kobayashi, Amina Bolatkan, Masaaki Komatsu, Masayoshi Yamada, Mototaka Miyake, Hirokazu Watanabe, Akiko Tateishi, Takaaki Mizuno, Yu Okubo, Masami Mukai, Tatsuya Yoshida, Yukihiro Yoshida8 Hidehito Horinouchi, Shun-Ichi Watanabe, Yuichiro Ohe, Yasushi Yatabe, Takashi Kohno (* Corresponding Author), Ryuji Hamamoto (* Corresponding Author)
For more information, please see the Molecular Cancer.
